Artículos de revistas sobre el tema "Cardiac hypertrophy"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Cardiac hypertrophy".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Li, Wei-ming, Yi-fan Zhao, Guo-fu Zhu, Wen-hui Peng, Meng-yun Zhu, Xue-jing Yu, Wei Chen, Da-chun Xu y Ya-wei Xu. "Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload". Clinical Science 131, n.º 2 (23 de diciembre de 2016): 141–54. http://dx.doi.org/10.1042/cs20160664.
Texto completoWehbe, Nadine, Suzanne Nasser, Gianfranco Pintus, Adnan Badran, Ali Eid y Elias Baydoun. "MicroRNAs in Cardiac Hypertrophy". International Journal of Molecular Sciences 20, n.º 19 (23 de septiembre de 2019): 4714. http://dx.doi.org/10.3390/ijms20194714.
Texto completoStrøm, Claes C., Mogens Kruhøffer, Steen Knudsen, Frank Stensgaard-Hansen, Thomas E. N. Jonassen, Torben F. Ørntoft, Stig Haunsø y Søren P. Sheikh. "Identification of a Core Set of Genes That Signifies Pathways Underlying Cardiac Hypertrophy". Comparative and Functional Genomics 5, n.º 6-7 (2004): 459–70. http://dx.doi.org/10.1002/cfg.428.
Texto completoBazgir, Farhad, Julia Nau, Saeideh Nakhaei-Rad, Ehsan Amin, Matthew J. Wolf, Jeffry J. Saucerman, Kristina Lorenz y Mohammad Reza Ahmadian. "The Microenvironment of the Pathogenesis of Cardiac Hypertrophy". Cells 12, n.º 13 (4 de julio de 2023): 1780. http://dx.doi.org/10.3390/cells12131780.
Texto completoZhang, Yan, Qiang Da, Siyi Cao, Ke Yan, Zhiguang Shi, Qing Miao, Chen Li et al. "HINT1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing HOXA5 (Homeobox A5) Expression". Circulation 144, n.º 8 (24 de agosto de 2021): 638–54. http://dx.doi.org/10.1161/circulationaha.120.051094.
Texto completoLu, Peilei, Danyu Zhang, Fan Ding, Jialu Ma, Yang K. Xiang y Meimi Zhao. "Silencing of circCacna1c Inhibits ISO-Induced Cardiac Hypertrophy through miR-29b-2-5p/NFATc1 Axis". Cells 12, n.º 12 (19 de junio de 2023): 1667. http://dx.doi.org/10.3390/cells12121667.
Texto completoLi, Yuhao, Yoshihiko Saito, Koichiro Kuwahara, Xianglu Rong, Ichiro Kishimoto, Masaki Harada, Yuichiro Adachi et al. "Guanylyl Cyclase-A Inhibits Angiotensin II Type 2 Receptor-Mediated Pro-Hypertrophic Signaling in the Heart". Endocrinology 150, n.º 8 (16 de abril de 2009): 3759–65. http://dx.doi.org/10.1210/en.2008-1353.
Texto completoLi, Yu, Bo He, Chao Zhang, Yanji He, Tianyang Xia y Chunyu Zeng. "Naringenin Attenuates Isoprenaline-Induced Cardiac Hypertrophy by Suppressing Oxidative Stress through the AMPK/NOX2/MAPK Signaling Pathway". Nutrients 15, n.º 6 (9 de marzo de 2023): 1340. http://dx.doi.org/10.3390/nu15061340.
Texto completoJohansson, Markus, Benyapa Tangruksa, Sepideh Heydarkhan-Hagvall, Anders Jeppsson, Peter Sartipy y Jane Synnergren. "Data Mining Identifies CCN2 and THBS1 as Biomarker Candidates for Cardiac Hypertrophy". Life 12, n.º 5 (12 de mayo de 2022): 726. http://dx.doi.org/10.3390/life12050726.
Texto completoHu, Chengyun, Feibiao Dai, Jiawu Wang, Lai Jiang, Di Wang, Jie Gao, Jun Huang et al. "Peroxiredoxin-5 Knockdown Accelerates Pressure Overload-Induced Cardiac Hypertrophy in Mice". Oxidative Medicine and Cellular Longevity 2022 (29 de enero de 2022): 1–12. http://dx.doi.org/10.1155/2022/5067544.
Texto completoRaghunathan, Suchi, Ramesh K. Goyal y Bhoomika M. Patel. "Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy". Canadian Journal of Physiology and Pharmacology 95, n.º 3 (marzo de 2017): 260–67. http://dx.doi.org/10.1139/cjpp-2016-0542.
Texto completoGallo, Simona, Annapia Vitacolonna, Alessandro Bonzano, Paolo Comoglio y Tiziana Crepaldi. "ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy". International Journal of Molecular Sciences 20, n.º 9 (1 de mayo de 2019): 2164. http://dx.doi.org/10.3390/ijms20092164.
Texto completoJohansson, Markus, Benjamin Ulfenborg, Christian X. Andersson, Sepideh Heydarkhan-Hagvall, Anders Jeppsson, Peter Sartipy y Jane Synnergren. "Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy". Life 12, n.º 2 (16 de febrero de 2022): 293. http://dx.doi.org/10.3390/life12020293.
Texto completoBi, Hai-Lian, Xiao-Li Zhang, Yun-Long Zhang, Xin Xie, Yun-Long Xia, Jie Du y Hui-Hua Li. "The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor". Science Advances 6, n.º 16 (abril de 2020): eaax4826. http://dx.doi.org/10.1126/sciadv.aax4826.
Texto completoDeng, Yawen, Zhitong Li, Xiangbo An, Rui Fan, Yao Wang, Jiatian Li, Xiaolei Yang, Jiawei Liao y Yunlong Xia. "Hyperhomocysteinemia Promotes Cardiac Hypertrophy in Hypertension". Oxidative Medicine and Cellular Longevity 2022 (22 de agosto de 2022): 1–16. http://dx.doi.org/10.1155/2022/1486157.
Texto completoGu, Wei, Yutong Cheng, Su Wang, Tao Sun y Zhizhong Li. "PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2". Cardiovascular Toxicology 21, n.º 6 (21 de febrero de 2021): 451–61. http://dx.doi.org/10.1007/s12012-021-09639-0.
Texto completoGolomb, E., Z. A. Abassi, G. Cuda, M. Stylianou, V. R. Panchal, D. Trachewsky y H. R. Keiser. "Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats". American Journal of Physiology-Heart and Circulatory Physiology 267, n.º 4 (1 de octubre de 1994): H1496—H1506. http://dx.doi.org/10.1152/ajpheart.1994.267.4.h1496.
Texto completoHarmsen, Eef y Frans H. H. Leenen. "Dietary sodium induced cardiac hypertrophy". Canadian Journal of Physiology and Pharmacology 70, n.º 4 (1 de abril de 1992): 580–86. http://dx.doi.org/10.1139/y92-073.
Texto completoCooper, George. "Cytoskeletal networks and the regulation of cardiac contractility: microtubules, hypertrophy, and cardiac dysfunction". American Journal of Physiology-Heart and Circulatory Physiology 291, n.º 3 (septiembre de 2006): H1003—H1014. http://dx.doi.org/10.1152/ajpheart.00132.2006.
Texto completoGao, Si, Xue-ping Liu, Li-hua Wei, Jing Lu y Peiqing Liu. "Upregulation of α-enolase protects cardiomyocytes from phenylephrine-induced hypertrophy". Canadian Journal of Physiology and Pharmacology 96, n.º 4 (abril de 2018): 352–58. http://dx.doi.org/10.1139/cjpp-2017-0282.
Texto completoLi, Peng-Long, Hui Liu, Guo-Peng Chen, Ling Li, Hong-Jie Shi, Hong-Yu Nie, Zhen Liu et al. "STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy". Hypertension 76, n.º 4 (octubre de 2020): 1219–30. http://dx.doi.org/10.1161/hypertensionaha.120.14752.
Texto completoTappia, Paramjit, Vijayan Elimban y Naranjan Dhalla. "Involvement of phospholipase C in the norepinephrine-induced hypertrophic response in Cardiomyocytes". Scripta Medica 53, n.º 2 (2022): 149–57. http://dx.doi.org/10.5937/scriptamed53-36527.
Texto completoXie, Xin, Hai-Lian Bi, Song Lai, Yun-Long Zhang, Nan Li, Hua-Jun Cao, Ling Han, Hong-Xia Wang y Hui-Hua Li. "The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation". Science Advances 5, n.º 5 (mayo de 2019): eaau0495. http://dx.doi.org/10.1126/sciadv.aau0495.
Texto completoRuzicka, M. y F. H. Leenen. "Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats". American Journal of Physiology-Heart and Circulatory Physiology 265, n.º 5 (1 de noviembre de 1993): H1551—H1556. http://dx.doi.org/10.1152/ajpheart.1993.265.5.h1551.
Texto completoSari, Nurmila, Yasufumi Katanasaka, Hiroki Honda, Yusuke Miyazaki, Yoichi Sunagawa, Masafumi Funamoto, Kana Shimizu et al. "Cacao Bean Polyphenols Inhibit Cardiac Hypertrophy and Systolic Dysfunction in Pressure Overload-induced Heart Failure Model Mice". Planta Medica 86, n.º 17 (9 de julio de 2020): 1304–12. http://dx.doi.org/10.1055/a-1191-7970.
Texto completoChung, Eunhee, Fan Yeung y Leslie A. Leinwand. "Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation". Journal of Applied Physiology 112, n.º 9 (1 de mayo de 2012): 1564–75. http://dx.doi.org/10.1152/japplphysiol.00027.2012.
Texto completoLiu, Yao-Lung, Chiu-Ching Huang, Chiz-Chung Chang, Che-Yi Chou, Shih-Yi Lin, I.-Kuan Wang, Dennis Jine-Yuan Hsieh, Gwo-Ping Jong, Chih-Yang Huang y Chao-Min Wang. "Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment". Cardiorenal Medicine 5, n.º 2 (2015): 79–88. http://dx.doi.org/10.1159/000371454.
Texto completoKee, Hae Jin y Hyun Kook. "Roles and Targets of Class I and IIa Histone Deacetylases in Cardiac Hypertrophy". Journal of Biomedicine and Biotechnology 2011 (2011): 1–10. http://dx.doi.org/10.1155/2011/928326.
Texto completoZeng, Si-yu, Qiu-jiang Yan, Li Yang, Qing-hua Mei y Hui-qin Lu. "Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2". Mediators of Inflammation 2020 (4 de agosto de 2020): 1–14. http://dx.doi.org/10.1155/2020/1078365.
Texto completoLi, Shujun, Bo Huang, Changfei Zhou, Jingshan Shi, Qin Wu y Qingsong Jiang. "Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II". Evidence-Based Complementary and Alternative Medicine 2021 (15 de enero de 2021): 1–8. http://dx.doi.org/10.1155/2021/8857329.
Texto completoGopinath, Bamini, Ronald J. Trent y Bing Yu. "Molecular characterisation of neonatal cardiac hypertrophy and its regression". Cardiology in the Young 14, n.º 5 (octubre de 2004): 498–505. http://dx.doi.org/10.1017/s1047951104005062.
Texto completoYan, Xiaoying, Ran Zhao, Xiaorong Feng, Jingzhou Mu, Ying Li, Yue Chen, Chunmei Li et al. "Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway". Cardiovascular Research 116, n.º 1 (11 de marzo de 2019): 114–26. http://dx.doi.org/10.1093/cvr/cvz064.
Texto completoDorn, Lisa E., William Lawrence, Jennifer M. Petrosino, Xianyao Xu, Thomas J. Hund, Bryan A. Whitson, Matthew S. Stratton et al. "Microfibrillar-Associated Protein 4 Regulates Stress-Induced Cardiac Remodeling". Circulation Research 128, n.º 6 (19 de marzo de 2021): 723–37. http://dx.doi.org/10.1161/circresaha.120.317146.
Texto completoXie, Yifan, Yang Gao, Rifeng Gao, Wenlong Yang, Zheng Dong, Robb E. Moses, Aijun Sun, Xiaotao Li y Junbo Ge. "The proteasome activator REGγ accelerates cardiac hypertrophy by declining PP2Acα–SOD2 pathway". Cell Death & Differentiation 27, n.º 10 (18 de mayo de 2020): 2952–72. http://dx.doi.org/10.1038/s41418-020-0554-8.
Texto completoYu, Qing, Wenxin Kou, Xu Xu, Shunping Zhou, Peipei Luan, Xiaopeng Xu, Hailing Li et al. "FNDC5/Irisin inhibits pathological cardiac hypertrophy". Clinical Science 133, n.º 5 (1 de marzo de 2019): 611–27. http://dx.doi.org/10.1042/cs20190016.
Texto completoXu, Si-Chi, Zhen-Guo Ma, Wen-Ying Wei, Yu-Pei Yuan y Qi-Zhu Tang. "Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis". PPAR Research 2017 (2017): 1–12. http://dx.doi.org/10.1155/2017/5789714.
Texto completoGeraets, Ilvy M. E., Will A. Coumans, Agnieszka Strzelecka, Patrick Schönleitner, Gudrun Antoons, Francesco Schianchi, Myrthe M. A. Willemars et al. "Metabolic Interventions to Prevent Hypertrophy-Induced Alterations in Contractile Properties In Vitro". International Journal of Molecular Sciences 22, n.º 7 (31 de marzo de 2021): 3620. http://dx.doi.org/10.3390/ijms22073620.
Texto completoZhang, Ning, Wen-Ying Wei, Zheng Yang, Yan Che, Ya-Ge Jin, Hai-Han Liao, Sha-sha Wang, Wei Deng y Qi-Zhu Tang. "Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress". Cellular Physiology and Biochemistry 42, n.º 4 (2017): 1313–25. http://dx.doi.org/10.1159/000478960.
Texto completoYao, Rui, Lingyao Kong, Chunlei Yang, Jiaqi Du, Guojun Zhao y Yapeng Li. "Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Ameliorates Cardiac Hypertrophy by Targeting TLR4 in Macrophages". Oxidative Medicine and Cellular Longevity 2022 (26 de abril de 2022): 1–13. http://dx.doi.org/10.1155/2022/9469143.
Texto completoVilleneuve, C., A. Caudrillier, C. Ordener, N. Pizzinat, A. Parini y J. Mialet-Perez. "Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells". American Journal of Physiology-Heart and Circulatory Physiology 297, n.º 2 (agosto de 2009): H821—H828. http://dx.doi.org/10.1152/ajpheart.00345.2009.
Texto completoLucas, Aline Maria Brito, Joana Varlla de Lacerda Alexandre, Maria Thalyne Silva Araújo, Cicera Edna Barbosa David, Yuana Ivia Ponte Viana, Beatriz Neves Coelho, Francisco Rodrigo Lemos Caldas, Anna Lídia Nunes Varela, Alicia Juliana Kowaltowski y Heberty Tarso Facundo. "Diazoxide Modulates Cardiac Hypertrophy by Targeting H2O2 Generation and Mitochondrial Superoxide Dismutase Activity". Current Molecular Pharmacology 13, n.º 1 (15 de enero de 2020): 76–83. http://dx.doi.org/10.2174/1874467212666190723144006.
Texto completoLiu, Yaoqiu, Yahui Shen, Jingai Zhu, Ming Liu, Xing Li, Yumei Chen, Xiangqing Kong, Guixian Song y Lingmei Qian. "Cardiac-Specific PID1 Overexpression Enhances Pressure Overload-Induced Cardiac Hypertrophy in Mice". Cellular Physiology and Biochemistry 35, n.º 5 (2015): 1975–85. http://dx.doi.org/10.1159/000374005.
Texto completoMontiel, Virginie, Ramona Bella, Lauriane Y. M. Michel, Hrag Esfahani, Delphine De Mulder, Emma L. Robinson, Jean-Philippe Deglasse et al. "Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxide". Science Translational Medicine 12, n.º 564 (7 de octubre de 2020): eaay2176. http://dx.doi.org/10.1126/scitranslmed.aay2176.
Texto completoWei, Xiangxiang, Jiayu Jin, Jian Wu, Yunquan He, Jieyu Guo, Zhaohua Yang, Liang Chen et al. "Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway". Cardiovascular Research, 3 de junio de 2023. http://dx.doi.org/10.1093/cvr/cvad086.
Texto completoKwon, Duk-hwa, Gwang Hyeon Eom, Hae Jin Kee, Yoonseok Nam, Young Kuk Cho, Don-Kyu Kim, Jayoung Koo et al. "Abstract 071: Estrogen-related Receptor Gamma Induces Cardiac Hypertrophy By Activating Gata4". Circulation Research 113, suppl_1 (agosto de 2013). http://dx.doi.org/10.1161/res.113.suppl_1.a071.
Texto completoWang, Wei, Nian Liu, Li Xin, Yanfei Ruan, Xin Du, Rong Bai, Jianzeng Dong y ChangSheng Ma. "RETRACTED ARTICLE: Inhibition of miR-296-5p protects the heart from cardiac hypertrophy by targeting CACNG6". Gene Therapy, 16 de diciembre de 2019. http://dx.doi.org/10.1038/s41434-019-0109-0.
Texto completoSu, Haibi, Jie Xu, Zhenghua Su, Chenxi Xiao, Jinghuan Wang, Wen Zhong, Chen Meng, Di Yang y Yizhun Zhu. "Poly (ADP-ribose) polymerases 16 triggers pathological cardiac hypertrophy via activating IRE1α–sXBP1–GATA4 pathway". Cellular and Molecular Life Sciences 80, n.º 6 (23 de mayo de 2023). http://dx.doi.org/10.1007/s00018-023-04805-9.
Texto completoRind, Jubran, Nagib Chalfoun y Richard McNamara. "Cardiac amyloidosis: The great masquerader". Global Cardiology Science and Practice 2018, n.º 2 (23 de julio de 2018). http://dx.doi.org/10.21542/gcsp.2018.18.
Texto completoXiao, Zheng, Bin Kong, Hongjie Yang, Chang Dai, Jin Fang, Tianyou Qin y He Huang. "Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4". Frontiers in Cardiovascular Medicine 7 (26 de noviembre de 2020). http://dx.doi.org/10.3389/fcvm.2020.579036.
Texto completoChen, Wen-Jing, Yan Cheng, Wen Li, Xiao-Kang Dong, Jian-liang Wei, Chuan-Hua Yang y Yue-Hua Jiang. "Quercetin Attenuates Cardiac Hypertrophy by Inhibiting Mitochondrial Dysfunction Through SIRT3/PARP-1 Pathway". Frontiers in Pharmacology 12 (28 de octubre de 2021). http://dx.doi.org/10.3389/fphar.2021.739615.
Texto completo